Abstract |
Currently published studies have implicated that microRNAs ( miRNAs) including exosomes-encapsulated miRNAs play a critical role in rheumatoid arthritis (RA). Previously, we have found that exosomes-encapsulated miR-548a-3p was significantly decreased in serum samples from RA patients by miRNAs microarray analysis. However, little is known of the role of miR-548a-3p in the development and progression of RA. In this study, we aim to investigate the underlying molecular mechanisms of miR-548a-3p in RA, which will provide new insight into understanding the pathogenesis of RA and identifying novel therapeutics targets for this disease. As validated by quantitative real-time polymerase chain reaction (qRT-PCR), the expression of miR-548a-3p in serum exosomes and peripheral blood mononuclear cells (PBMCs) of RA patients (n = 76) was obviously down-regulated compared with healthy controls (n = 20). Serum exosomal miR-548a-3p was negatively associated with levels of CRP, RF, and ESR in serum of patients with RA. MiR-548a-3p could inhibit the proliferation and activation of pTHP-1 cells by regulating the TLR4/NF-κB signaling pathway. Accordingly, exosomes-delivered miR-548a-3p may be a critical factor predicting the disease activity of RA. MiR-548a-3p/TLR4/NF-κB axis can serve as promising targets for RA diagnosis and treatment.
|
Authors | Yingliang Wang, Feng Zheng, Guohong Gao, Shushan Yan, Laixia Zhang, Li Wang, Xiao Cai, Xiaodong Wang, Donghua Xu, Jibo Wang |
Journal | Journal of cellular biochemistry
(J Cell Biochem)
Vol. 120
Issue 2
Pg. 1133-1140
(Feb 2019)
ISSN: 1097-4644 [Electronic] United States |
PMID | 29315763
(Publication Type: Journal Article)
|
Copyright | © 2018 Wiley Periodicals, Inc. |